Jim Cramer Isn't Sure If There’s Upside In This Health Care Stock
Cramer favors Howmet, remains cautious on AeroVironment, Rocket, AtaiBeckley and MP Materials, citing competition and limited upside.
Stocks · News reference
President Trump Say In A Social Media Post That The University Of Miami Shared Its 1994 Ibogaine Investigational New Drug Application With The Government, Which Will Help Accelerate Development As A Medical Treatment In The U.S.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
AtaiBeckley Says Hart-Scott-Rodino Waiting Period For Merger With Eli Lilly Expired On Aug 28, 2026; UK Competition Authority Has No Further Questions On Merger As Of August 21, 2026
As previously disclosed, AtaiBeckley Inc. (the "Company") entered into an Agreement and Plan of Merger, dated as of July 15, 2026 (the "Merger Agreement"), with Eli Lilly and Company, an Indiana
8-K filing — AtaiBeckley Inc. (ATAI)
Filed: 2026-08-31 AccNo: 0001140361-26-035091 Size: 167 KB Item 8.01: Other Events
Shares if ibogaine-related biotech companies are trading higher after President Trump said in a social media post that the University of Miami shared its 1994 ibogaine Investigational New Drug Application with the government, which will help accelerate development as a medical treatment in the U.S.
Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting On August 18, 2026; Issues 165,000 Shares As Consideration For Asset Purchase
-SEC Filing
8-K filing — Silo Pharma, Inc. (SILO)
Filed: 2026-08-19 AccNo: 0001213900-26-091783 Size: 235 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits